Migraine Pathophysiology: Genetics, Brain Networks, Triggers, and Treatment Targets

Multifactorial Etiology

Migraine is a complex neurovascular disorder with strong genetic predisposition and environmental triggers.

1. Genetics

  • Polygenic; heritability ~40–50%.
  • Specific mutations: CACNA1A, ATP1A2, SCN1A (familial hemiplegic migraine).
  • Common variants (GWAS) implicate neuronal excitability, vascular tone, metal ion homeostasis.

2. Brain Abnormalities

  • Structural: cortical thickening/thinning, white matter hyperintensities.
  • Functional: hyperexcitable cortex, altered brainstem (periaqueductal gray) and hypothalamic activity.
  • Trigeminal vascular system sensitization.

3. Neurotransmitters

  • Serotonin (5-HT): Modulates pain pathways; triptans are 5-HT1B/1D agonists.
  • CGRP (calcitonin gene-related peptide): Key mediator; target of gepants (ubrogepant, rimegepant) and monoclonal antibodies (erenumab, fremanezumab, galcanezumab, eptinezumab).
  • Dopamine, glutamate: Modulatory roles.

4. Triggers (Individualized)

  • Hormonal (menstrual, oral contraceptives)
  • Stress (let-down after stress)
  • Dietary: aged cheese, alcohol (red wine), caffeine withdrawal, aspartame, nitrates
  • Sensory: bright light, strong smells, loud noise
  • Sleep: deprivation or oversleep
  • Weather: barometric pressure changes

5. Cortical Spreading Depression (CSD)

Wave of neuronal/glial depolarization spreading at 2–6 mm/min across cortex. Underlies migraine aura; activates trigeminal afferents → headache.

6. Vascular Changes

CSD and trigeminal activation cause neurogenic inflammation, vasodilation, and plasma protein extravasation → sensitization of meningeal nociceptors.

Treatment Landscape

  • Acute: NSAIDs, triptans, gepants, lasmiditan, antiemetics.
  • Preventive: beta-blockers, topiramate, CGRP mAbs, gepants, onabotulinumtoxinA (chronic).
  • Non-pharmacologic: CBT, biofeedback, trigger management, regular sleep/meals, hydration.

Personalized approach based on frequency, severity, comorbidities, and patient preference.

Migraine - Related Articles